Emerson Electric Company (EMR) reported $18.64B of revenue for the twelve months ended Jun 30, 2026. That is up 4.8% from the year before. Revenue for fiscal 2025 was $18.02B.

Yes. Emerson Electric Company earned $2.58B in net income for the twelve months ended Jun 30, 2026, a net margin of 13.8%.

How much cash and debt does EMR have?

Emerson Electric Company reported $2.18B in cash and cash equivalents and $13.11B of debt on its most recent balance sheet in SEC filings.

How fast is EMR revenue growing?

Emerson Electric Company's revenue changed +3.0% in fiscal 2025, to $18.02B. Its compound annual growth rate was +1.4% over 5 years and +1.0% over 10 years.

What is EMR gross margin?

Emerson Electric Company's gross profit was $9.91B on $18.64B of revenue for the twelve months ended Jun 30, 2026, a gross margin of 53.2%.

What is EMR free cash flow?

Emerson Electric Company generated $3.46B of free cash flow for the twelve months ended Jun 30, 2026, which is operating cash flow of $3.91B less capital expenditures.

What is EMR earnings per share?

Diluted earnings per share were $4.57 for the twelve months ended Jun 30, 2026, from SEC filings, restated for any stock split those filings show.

When did EMR last report financial results?

The latest statements here come from Emerson Electric Company's 10-Q filed on Aug 4, 2026, covering the period ended Jun 30, 2026.

Financials · EMR

Emerson Electric Company (EMR) financials

For the twelve months ended Jun 30, 2026, Emerson Electric Company reported $18.64B of revenue and $2.58B of net income.

Revenue, TTM: $18.64B
Revenue growth, YoY: +4.8%
Net income, TTM: $2.58B
Net income growth, YoY: -2.8%
Net margin: 13.8%
Free cash flow, TTM: $3.46B
EPS, diluted, TTM: $4.57
EPS growth, YoY: -1.7%
Cash: $2.18B
Total debt: $13.11B
P/E: 35.13
P/S: 4.86
Market cap: $90.56B

Annual revenue$18.02B

FY2016FY2025

Annual net income$2.29B

FY2016FY2025

Annual free cash flow$2.67B

FY2016FY2025

EMR revenue and earnings growth

EMR revenueQ3 2026$4.87B

Quarter YoY: +7.0%
QoQ: +6.8%
FY YoY: +3.0%
5Y CAGR: +1.4%
10Y CAGR: +1.0%

EMR revenue was $4.87B in fiscal Q3 2026 (ended Jun 30, 2026), up 7.0% from a year earlier and up 6.8% from the prior quarter. For the full fiscal 2025 it was $18.02B, up 3.0% from fiscal 2024. Compound annual growth was +1.4% over 5 years and +1.0% over 10 years. It rose in 7 of the last 10 fiscal years.

EMR net incomeQ3 2026$718.00M

Quarter YoY: +22.5%
QoQ: +16.2%
FY YoY: +16.5%
5Y CAGR: +3.1%
10Y CAGR: -1.7%

EMR net income was $718.00M in fiscal Q3 2026 (ended Jun 30, 2026), up 22.5% from a year earlier and up 16.2% from the prior quarter. For the full fiscal 2025 it was $2.29B, up 16.5% from fiscal 2024. Compound annual growth was +3.1% over 5 years and -1.7% over 10 years. It rose in 6 of the last 10 fiscal years.

EMR EPSQ3 2026$1.28

Quarter YoY: +23.1%
QoQ: +16.4%
FY YoY: +17.8%
5Y CAGR: +4.5%
10Y CAGR: +0.1%

EMR diluted EPS was $1.28 in fiscal Q3 2026 (ended Jun 30, 2026), up 23.1% from a year earlier and up 16.4% from the prior quarter. For the full fiscal 2025 it was $4.04, up 17.8% from fiscal 2024. Compound annual growth was +4.5% over 5 years and +0.1% over 10 years.

EMR free cash flowQ3 2026$1.32B

Quarter YoY: +35.3%
QoQ: +90.5%
FY YoY: -8.4%
5Y CAGR: +0.9%
10Y CAGR: +3.2%

EMR free cash flow was $1.32B in fiscal Q3 2026 (ended Jun 30, 2026), up 35.3% from a year earlier and up 90.5% from the prior quarter. For the full fiscal 2025 it was $2.67B, down 8.4% from fiscal 2024. Compound annual growth was +0.9% over 5 years and +3.2% over 10 years. It rose in 6 of the last 10 fiscal years.

Export CSV

Income statement

Income statement
Line item	FY2025 Sep 30, 2025	FY2024 Sep 30, 2024	FY2023 Sep 30, 2023	FY2022 Sep 30, 2022	FY2021 Sep 30, 2021	FY2020 Sep 30, 2020	FY2019 Sep 30, 2019	FY2018 Sep 30, 2018	FY2017 Sep 30, 2017	FY2016 Sep 30, 2016
Revenue	$18.02B	$17.49B	$15.16B	$13.80B	$12.93B	$16.79B	$18.37B	$17.41B	$15.26B	$14.52B
Cost of revenue	$8.50B	$8.61B	$7.74B	$7.50B	$7.20B	$9.78B	$10.56B	$9.98B	$8.83B	$8.26B
Gross profit	$9.52B	$8.88B	$7.43B	$6.31B	$7.56B	$7.01B	$7.82B	$7.43B	$6.40B	$6.26B
Research and development	$771.00M	$781.00M	$523.00M	$385.00M	$347.00M	$439.00M	$454.00M	$436.00M	$340.00M	$320.00M
Selling, general and admin	$5.10B	$5.14B	$4.19B	$3.61B	$3.49B	$3.99B	$4.46B	$4.27B	$3.61B	$3.46B
Interest expense	-	-	-	-	$147.00M	-	-	-	-	-
Pre-tax income	$2.93B	$2.02B	$2.90B	$2.43B	$1.76B	$2.33B	$2.86B	$2.67B	$2.33B	$2.32B
Income tax	$696.00M	$415.00M	$642.00M	$549.00M	$346.00M	$345.00M	$531.00M	$443.00M	$660.00M	$697.00M
Net income	$2.29B	$1.97B	$13.22B	$3.23B	$2.30B	$1.97B	$2.31B	$2.20B	$1.52B	$1.64B
EPS, basic	$4.06	$3.44	$23.00	$5.44	$3.85	$3.26	$3.74	$3.48	$2.35	$2.53
EPS, diluted	$4.04	$3.43	$22.88	$5.41	$3.82	$3.24	$3.71	$3.46	$2.35	$2.52
Diluted shares	566.7M	574.0M	577.3M	596.3M	601.8M	606.6M	620.6M	635.3M	643.4M	646.8M

Balance sheet

Balance sheet
Line item	FY2025 Sep 30, 2025	FY2024 Sep 30, 2024	FY2023 Sep 30, 2023	FY2022 Sep 30, 2022	FY2021 Sep 30, 2021	FY2020 Sep 30, 2020	FY2019 Sep 30, 2019	FY2018 Sep 30, 2018	FY2017 Sep 30, 2017	FY2016 Sep 30, 2016
Cash and equivalents	$1.54B	$3.59B	$8.05B	$1.80B	$2.35B	$3.31B	$1.49B	$1.09B	$3.06B	$3.18B
Short-term investments	-	-	-	-	-	-	-	-	-	$99.00M
Receivables	$3.10B	$2.93B	$2.52B	$2.26B	$2.97B	$2.80B	$2.98B	$3.02B	$3.07B	$2.70B
Inventory	$2.21B	$2.18B	$2.01B	$1.74B	$2.05B	$1.93B	$1.88B	$1.81B	$1.70B	$1.21B
Current assets	$8.58B	$10.19B	$13.82B	$8.51B	$8.43B	$8.81B	$7.14B	$6.62B	$8.25B	$9.96B
Goodwill	$18.19B	$18.07B	$14.48B	$13.95B	$6.97B	$6.73B	$6.54B	$6.46B	$5.32B	$3.91B
Total assets	$41.96B	$44.25B	$42.75B	$35.67B	$24.71B	$22.88B	$20.50B	$20.39B	$19.59B	$21.73B
Current liabilities	$9.80B	$5.74B	$5.03B	$7.78B	$6.25B	$5.79B	$5.98B	$6.16B	$5.04B	$8.01B
Short-term debt	$4.80B	$532.00M	$547.00M	$2.12B	$872.00M	$1.16B	$1.44B	$1.62B	$862.00M	$2.58B
Long-term debt	$8.32B	$7.16B	$7.61B	$8.26B	$5.79B	$6.33B	$4.28B	$3.14B	$3.79B	$4.05B
Total debt	$13.12B	$7.69B	$8.16B	$10.37B	$6.67B	$7.49B	$5.72B	$4.76B	$4.66B	$6.63B
Total liabilities	$21.67B	$16.74B	$16.15B	$19.36B	$14.79B	$14.44B	$12.22B	$11.40B	$10.82B	$14.11B
Shareholders' equity	$20.28B	$21.64B	$26.60B	$16.32B	$9.92B	$8.40B	$8.23B	$8.95B	$8.72B	$7.57B

Cash flow

Cash flow
Line item	FY2025 Sep 30, 2025	FY2024 Sep 30, 2024	FY2023 Sep 30, 2023	FY2022 Sep 30, 2022	FY2021 Sep 30, 2021	FY2020 Sep 30, 2020	FY2019 Sep 30, 2019	FY2018 Sep 30, 2018	FY2017 Sep 30, 2017	FY2016 Sep 30, 2016
Operating cash flow	$3.10B	$3.33B	$637.00M	$2.92B	$3.58B	$3.08B	$3.01B	$2.89B	$1.91B	$2.88B
Capital expenditures	$431.00M	$419.00M	$363.00M	$299.00M	$404.00M	$538.00M	$594.00M	$617.00M	$476.00M	$447.00M
Free cash flow	$2.67B	$2.91B	$274.00M	$2.62B	$3.17B	$2.54B	$2.41B	$2.27B	$1.44B	$2.43B
Investing cash flow	-$593.00M	-$5.36B	$12.41B	-$5.33B	-$2.12B	-$740.00M	-$1.17B	-$2.72B	$1.51B	-$626.00M
Financing cash flow	-$4.51B	-$2.46B	-$6.82B	$2.05B	-$2.42B	-$509.00M	-$1.39B	-$2.09B	-$3.59B	-$2.04B
Dividends paid	$1.19B	$1.20B	$1.20B	$1.22B	$1.21B	$1.21B	$1.21B	$1.23B	$1.24B	$1.23B
Share repurchases	$1.17B	$435.00M	$2.00B	$500.00M	$500.00M	$942.00M	$1.25B	$1.00B	$400.00M	$601.00M
Stock-based compensation	$263.00M	$260.00M	$250.00M	$125.00M	$197.00M	$110.00M	$120.00M	$216.00M	$110.00M	-
Depreciation and amortization	$1.52B	$1.69B	$1.05B	$842.00M	$762.00M	$854.00M	$822.00M	$758.00M	$636.00M	$568.00M

Key ratios

Key ratios
Line item	FY2025 Sep 30, 2025	FY2024 Sep 30, 2024	FY2023 Sep 30, 2023	FY2022 Sep 30, 2022	FY2021 Sep 30, 2021	FY2020 Sep 30, 2020	FY2019 Sep 30, 2019	FY2018 Sep 30, 2018	FY2017 Sep 30, 2017	FY2016 Sep 30, 2016
Revenue growth, YoY	3.0%	15.3%	9.9%	6.7%	-23.0%	-8.6%	5.5%	14.0%	5.1%	-10.6%
Net income growth, YoY	16.5%	-85.1%	309.1%	40.3%	17.2%	-14.8%	4.7%	45.1%	-7.2%	-39.7%
EPS growth, YoY	17.8%	-85.0%	322.9%	41.6%	17.9%	-12.7%	7.2%	47.2%	-6.7%	-36.8%
Gross margin	52.8%	50.8%	49.0%	45.7%	58.5%	41.8%	42.5%	42.7%	42.0%	43.1%
Net margin	12.7%	11.3%	87.2%	23.4%	17.8%	11.7%	12.6%	12.7%	9.9%	11.3%
Free cash flow margin	14.8%	16.7%	1.8%	19.0%	24.5%	15.2%	13.1%	13.1%	9.4%	16.8%
Return on equity	11.3%	9.1%	49.7%	19.8%	23.2%	23.4%	28.0%	24.6%	17.4%	21.6%
Return on assets	5.5%	4.4%	30.9%	9.1%	9.3%	8.6%	11.3%	10.8%	7.7%	7.5%
Current ratio	0.88	1.77	2.75	1.09	1.35	1.52	1.19	1.07	1.64	1.24
Debt to equity	0.65	0.36	0.31	0.64	0.67	0.89	0.69	0.53	0.53	0.88

Income statement

Income statement
Line item	Q3 2026 Jun 30, 2026	Q2 2026 Mar 31, 2026	Q1 2026 Dec 31, 2025	Q4 2025 Sep 30, 2025	Q3 2025 Jun 30, 2025	Q2 2025 Mar 31, 2025	Q1 2025 Dec 31, 2024	Q4 2024 Sep 30, 2024	Q3 2024 Jun 30, 2024	Q2 2024 Mar 31, 2024	Q1 2024 Dec 31, 2023	Q4 2023 Sep 30, 2023
Revenue	$4.87B	$4.56B	$4.35B	$4.86B	$4.55B	$4.43B	$4.17B	$4.62B	$4.38B	$4.38B	$4.12B	$4.09B
Cost of revenue	$2.22B	$2.14B	$2.04B	$2.34B	$2.16B	$2.06B	$1.94B	$2.25B	$2.07B	$2.09B	$2.20B	$2.08B
Gross profit	$2.65B	$2.42B	$2.31B	$2.52B	$2.39B	$2.37B	$2.23B	$2.37B	$2.31B	$2.28B	$1.92B	$2.01B
Selling, general and admin	$1.34B	$1.32B	$1.24B	$1.33B	$1.27B	$1.28B	$1.22B	$1.31B	$1.25B	$1.30B	$1.28B	$1.11B
Pre-tax income	$916.00M	$793.00M	$775.00M	$796.00M	$734.00M	$629.00M	$775.00M	$679.00M	$455.00M	$711.00M	$175.00M	$1.02B
Income tax	$198.00M	$175.00M	$169.00M	$160.00M	$154.00M	$199.00M	$182.00M	$149.00M	$88.00M	$162.00M	$16.00M	$242.00M
Net income	$718.00M	$618.00M	$605.00M	$637.00M	$586.00M	$485.00M	$585.00M	$996.00M	$329.00M	$501.00M	$142.00M	$744.00M
EPS, basic	$1.28	$1.10	$1.08	$1.13	$1.04	$0.86	$1.03	$1.74	$0.58	$0.88	$0.25	$1.30
EPS, diluted	$1.28	$1.10	$1.07	$1.12	$1.04	$0.86	$1.02	$1.73	$0.57	$0.87	$0.25	$1.29
Diluted shares	561.1M	563.0M	564.1M	-	564.7M	565.4M	571.1M	-	574.8M	574.1M	573.3M	-

Balance sheet

Balance sheet
Line item	Q3 2026 Jun 30, 2026	Q2 2026 Mar 31, 2026	Q1 2026 Dec 31, 2025	Q4 2025 Sep 30, 2025	Q3 2025 Jun 30, 2025	Q2 2025 Mar 31, 2025	Q1 2025 Dec 31, 2024	Q4 2024 Sep 30, 2024	Q3 2024 Jun 30, 2024	Q2 2024 Mar 31, 2024	Q1 2024 Dec 31, 2023	Q4 2023 Sep 30, 2023
Cash and equivalents	$2.18B	$1.79B	$1.75B	$1.54B	$2.22B	$1.89B	$2.83B	$3.59B	$2.30B	$2.32B	$2.08B	$8.05B
Receivables	$3.06B	$3.16B	$2.97B	$3.10B	$2.91B	$2.90B	$2.69B	$2.93B	$2.76B	$2.88B	$2.76B	$2.52B
Inventory	$2.51B	$2.45B	$2.35B	$2.21B	$2.29B	$2.22B	$2.20B	$2.18B	$2.30B	$2.36B	$2.43B	$2.01B
Current assets	$9.65B	$9.25B	$8.84B	$8.58B	$9.07B	$8.63B	$9.19B	$10.19B	$8.82B	$9.01B	$8.67B	$13.82B
Goodwill	$18.12B	$18.15B	$18.18B	$18.19B	$18.16B	$18.00B	$17.91B	$18.07B	$17.94B	$17.96B	$17.98B	$14.48B
Total assets	$42.21B	$42.09B	$41.94B	$41.96B	$42.52B	$41.98B	$42.61B	$44.25B	$45.59B	$46.44B	$46.51B	$42.75B
Current liabilities	$10.77B	$10.65B	$10.52B	$9.80B	$10.73B	$10.85B	$5.96B	$5.74B	$7.59B	$7.66B	$7.76B	$5.03B
Short-term debt	$5.59B	$5.80B	$5.83B	$4.80B	$5.95B	$6.19B	$1.07B	$532.00M	$2.99B	$3.15B	$3.23B	$547.00M
Long-term debt	$7.53B	$7.55B	$7.58B	$8.32B	$8.28B	$8.18B	$6.56B	$7.16B	$7.11B	$7.61B	$7.63B	$7.61B
Total debt	$13.11B	$13.36B	$13.41B	$13.12B	$14.23B	$14.36B	$7.62B	$7.69B	$10.10B	$10.77B	$10.86B	$8.16B
Total liabilities	$21.81B	$21.77B	$21.65B	$21.67B	$22.63B	$22.71B	$16.23B	$16.74B	$18.90B	$19.66B	$19.96B	$16.15B
Shareholders' equity	$20.38B	$20.30B	$20.28B	$20.28B	$19.89B	$19.27B	$26.38B	$21.64B	$26.69B	$26.78B	$26.55B	$26.60B

Cash flow

Cash flow
Line item	Q3 2026 Jun 30, 2026	Q2 2026 Mar 31, 2026	Q1 2026 Dec 31, 2025	Q4 2025 Sep 30, 2025	Q3 2025 Jun 30, 2025	Q2 2025 Mar 31, 2025	Q1 2025 Dec 31, 2024	Q4 2024 Sep 30, 2024	Q3 2024 Jun 30, 2024	Q2 2024 Mar 31, 2024	Q1 2024 Dec 31, 2023	Q4 2023 Sep 30, 2023
Operating cash flow	$1.42B	$779.00M	$699.00M	$1.01B	$1.07B	$241.00M	$777.00M	$1.08B	$1.09B	$743.00M	$415.00M	-$643.00M
Capital expenditures	$102.00M	$85.00M	$97.00M	$168.00M	$93.00M	$87.00M	$83.00M	$168.00M	$92.00M	$82.00M	$77.00M	$169.00M
Free cash flow	$1.32B	$694.00M	$602.00M	$842.00M	$977.00M	$154.00M	$694.00M	$916.00M	$998.00M	$661.00M	$338.00M	-$812.00M
Investing cash flow	-$116.00M	-$81.00M	-$125.00M	-$200.00M	-$129.00M	-$122.00M	-$142.00M	$3.20B	-$75.00M	-$37.00M	-$8.45B	-$685.00M
Financing cash flow	-$907.00M	-$649.00M	-$364.00M	-$1.49B	-$637.00M	-$1.09B	-$1.29B	-$3.04B	-$1.03B	-$442.00M	$2.06B	-$521.00M
Dividends paid	$311.00M	$312.00M	$312.00M	$297.00M	$297.00M	$297.00M	$301.00M	$300.00M	$301.00M	$300.00M	$300.00M	$298.00M
Share repurchases	$356.00M	$292.00M	$250.00M	$20.00M	$25.00M	$223.00M	$899.00M	$260.00M	$0	$0	$175.00M	$0
Stock-based compensation	$68.00M	$58.00M	$55.00M	$65.00M	$71.00M	$59.00M	$68.00M	$57.00M	$56.00M	$73.00M	$74.00M	$52.00M
Depreciation and amortization	$377.00M	$369.00M	$359.00M	$379.00M	$372.00M	$384.00M	$383.00M	$426.00M	$417.00M	$424.00M	$422.00M	$271.00M

Key ratios

Key ratios
Line item	Q3 2026 Jun 30, 2026	Q2 2026 Mar 31, 2026	Q1 2026 Dec 31, 2025	Q4 2025 Sep 30, 2025	Q3 2025 Jun 30, 2025	Q2 2025 Mar 31, 2025	Q1 2025 Dec 31, 2024	Q4 2024 Sep 30, 2024	Q3 2024 Jun 30, 2024	Q2 2024 Mar 31, 2024	Q1 2024 Dec 31, 2023	Q4 2023 Sep 30, 2023
Revenue growth, YoY	7.0%	2.9%	4.1%	5.1%	3.9%	1.3%	1.4%	12.9%	11.0%	16.5%	22.1%	5.1%
Net income growth, YoY	22.5%	27.4%	3.4%	-36.0%	78.1%	-3.2%	312.0%	33.9%	-96.5%	-36.7%	-93.9%	0.5%
EPS growth, YoY	23.1%	27.9%	4.9%	-35.3%	82.5%	-1.1%	308.0%	34.1%	-96.5%	-37.0%	-93.7%	4.0%
Gross margin	54.5%	53.1%	53.2%	51.9%	52.6%	53.5%	53.5%	51.3%	52.8%	52.2%	46.5%	49.2%
Net margin	14.7%	13.5%	13.9%	13.1%	12.9%	10.9%	14.0%	21.6%	7.5%	11.4%	3.4%	18.2%
Free cash flow margin	27.1%	15.2%	13.9%	17.3%	21.5%	3.5%	16.6%	19.8%	22.8%	15.1%	8.2%	-19.9%
Current ratio	0.90	0.87	0.84	0.88	0.85	0.80	1.54	1.77	1.16	1.18	1.12	2.75
Debt to equity	0.64	0.66	0.66	0.65	0.72	0.75	0.29	0.36	0.38	0.40	0.41	0.31

Source: XBRL data Emerson Electric Company files with the SEC, latest filing dated Aug 4, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.

Per-share figures are as filed. The filings show no stock split in these periods.

EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.

EMR peers

Company	Revenue	Growth	Net income	Net margin	Market cap
EMR	$18.64B	+4.8%	$2.58B	13.8%	$90.56B
GEGE Aerospace	$52.58B	+19.6%	$9.10B	17.3%	$334.02B
GEVGE Vernova Inc.	$44.04B	+16.9%	$10.37B	23.5%	$204.89B
SONYSony Group Corporation	¥12.48T	+3.7%	-¥326.87B	-2.6%	$159.16B
SNSharkNinja Inc.	$7.26B	-	$844.85M	11.6%	$31.42B
OTISOtis Worldwide Corporation	$15.13B	+5.8%	$1.56B	10.3%	$30.06B
AOSA.O. Smith Corporation	$3.80B	-0.7%	$494.60M	13.0%	$8.67B
KNKnowles Corporation	$666.10M	+16.1%	$71.70M	10.8%	$2.65B
WHRWhirlpool Corporation	$14.56B	-6.4%	-$123.00M	-0.8%	$2.01B

EMR FAQ

9 questions

What is EMR revenue?
Emerson Electric Company (EMR) reported $18.64B of revenue for the twelve months ended Jun 30, 2026. That is up 4.8% from the year before. Revenue for fiscal 2025 was $18.02B.
Is EMR profitable?
Yes. Emerson Electric Company earned $2.58B in net income for the twelve months ended Jun 30, 2026, a net margin of 13.8%.
How much cash and debt does EMR have?
Emerson Electric Company reported $2.18B in cash and cash equivalents and $13.11B of debt on its most recent balance sheet in SEC filings.
How fast is EMR revenue growing?
Emerson Electric Company's revenue changed +3.0% in fiscal 2025, to $18.02B. Its compound annual growth rate was +1.4% over 5 years and +1.0% over 10 years.
What is EMR gross margin?
Emerson Electric Company's gross profit was $9.91B on $18.64B of revenue for the twelve months ended Jun 30, 2026, a gross margin of 53.2%.
What is EMR free cash flow?
Emerson Electric Company generated $3.46B of free cash flow for the twelve months ended Jun 30, 2026, which is operating cash flow of $3.91B less capital expenditures.
What is EMR earnings per share?
Diluted earnings per share were $4.57 for the twelve months ended Jun 30, 2026, from SEC filings, restated for any stock split those filings show.
When did EMR last report financial results?
The latest statements here come from Emerson Electric Company's 10-Q filed on Aug 4, 2026, covering the period ended Jun 30, 2026.
Where does this EMR financial data come from?
Quantisnow builds these statements from the structured XBRL data Emerson Electric Company files with the SEC. It is provided for information only and is not investment advice.